Nanalysis closes $2.5 million first tranche, upsizes private placement

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) closed the first tranche of its non-brokered private placement, issuing 16,526,283 units at $0.15 per unit for gross proceeds of approximately $2.5 million.

The Calgary-based company announced it has increased the size of the offering due to investor demand. The upsize will allow for the issuance of up to an additional 23,333,333 units at $0.15 per unit for aggregate gross proceeds of up to $3.5 million, subject to TSX Venture Exchange approval.

Each unit consists of one common share and one-half of one warrant. The warrants allow holders to purchase additional shares at $0.20 per share for two years from the closing date. The company may accelerate warrant expiry to 30 days after notice if shares trade at or above $0.30 for 10 consecutive trading days.

Net proceeds will be used for debt reduction and magnet inventory purchases, according to the company's press release. The company expects to close the second tranche in January 2026.

Sean Krakiwsky, a company insider, purchased $52,500 worth of units in the first tranche. The company paid $1,500 in finder's fees to Haywood Securities Inc. and may pay up to 5% finder's fees on additional proceeds from registered investment advisors.

All securities from the first tranche are subject to a four-month-and-one-day statutory hold period. The offering remains subject to final TSX Venture Exchange acceptance.

Nanalysis develops portable Nuclear Magnetic Resonance spectrometers for pharmaceutical, biotech, energy, food, materials and security industries. The company operates a services division with a $160 million long-term contract with the Canadian Air Transport Security Authority to maintain security scanners at more than 80 Canadian airports.

You May Also Be Interested In

• OpenAI to acquire cloud execution company Ona
• Adial Pharmaceuticals acquires Azora Therapeutics for up to $64 million
• Edesa Biotech raises $3.5 million in private placement led by CEO